Mereo BioPharma, the Osteogenesis Imperfecta Federation Europe (OIFE) and the Osteogenesis Imperfecta Foundation (OIF) announces completion of the IMPACT Survey enrollment

Ads

You May Also Like

FIT Biotech Oy: FIT Biotech granted U.S. patent for treating HIV

FIT Biotech Oy  Company release 30.11.2017 at 9.30 FIT Biotech granted U.S. patent for ...

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care              Lugano, Switzerland, ...